Advanced search
Publication Cover
Pharmacogenomics Volume 11, 2010 - Issue 6
Submit an article Journal homepage
428
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

HLA-B*5901 is Strongly Associated with Methazolamide-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis

Sae-Hoon Kim1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea;2 Institute of Allergy & Clinical Immunology, Seoul National University College of Medicine, Seoul, South Korea;3 Department of Internal Medicine, Seoul National University, Bundang Hospital, Seongnam, South KoreaView further author information
,
Myunghwa Kim4 Department of Dermatology, Dankook University College of Medicine, Cheonan, South KoreaView further author information
,
Kyung Wha Lee5 Hallym Institute for Genome Application, Hallym University, Anyang, South KoreaView further author information
,
Sang-Heon Kim6 Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South KoreaView further author information
,
Hye-Ryun Kang1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea;2 Institute of Allergy & Clinical Immunology, Seoul National University College of Medicine, Seoul, South KoreaView further author information
,
Heung-Woo Park1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea;2 Institute of Allergy & Clinical Immunology, Seoul National University College of Medicine, Seoul, South KoreaView further author information
&
Young-Koo Jee7 Department of Internal Medicine, Dankook University College of Medicine, Cheonan, South Korea. Tel.: +82 415 503 923 Fax: +82 415 563 [email protected]View further author information
 show all
Pages 879-884 | Published online: 27 May 2010

Bibliography

  • Flach AJ , SmithRE, FlaunfelderFT: Stevens–Johnson syndrome associated with methazolamide treatment reported in two Japanese–American women.Ophthalmology102(11) , 1677–1680 (1995).
  • Shirato S , KagayaF, SuzukiY, JoukouS: Stevens–Johnson syndrome induced by methazolamide treatment.Arch. Ophthalmol.115(4) , 550–553 (1997).
  • Roujeau JC , SternRS: Severe adverse cutaneous reactions to drugs.N. Engl. J. Med.331(19) , 1272–1285 (1994).
  • Cotter JB : Methazolamide-induced Stevens–Johnson syndrome: a warning!Arch. Ophthalmol.116(1) , 117 (1998).
  • Park YJ , MoonJI, ParkCK: Three cases of Stevens–Johnson syndrome associated with methazolamide treatment.J. Korean Ophthalmol. Soc.40(2) , 613–618 (1999).
  • Moon JI , SeoJH, ParkCK: Association of HLA type with Stevens–Johnson syndrome induced by methazolamide treatment.J. Korean Ophthalmol. Soc.41(10) , 2241–2246 (2000).
  • Ahn EY , LeeJB, LeeSC, WonYH: Four cases of Stevens–Johnson syndrome associated with methazolamide treatment.Korean Dermatol.38(6) , 798–801 (2000).
  • Sung KH , JwongY, ChoiHU, LeeSK: Two cases of HLA-B59(+) Stevens–Johnson syndrome (SJS)–toxic epidermal necrolysis (TEN) associated with methazolamide treatment.Korean Dermatol.43(4) , 561–563 (2005).
  • Lee KW , OhHD, LeeC, YangSY: Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population.Tissue Antigens65(5) , 437–447 (2005).
  • Saito S , OtaS, YamadaE, InokoH, OtaM: Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.Tissue Antigens56(6) , 522–529 (2000).
  • Roujeau JC : The spectrum of Stevens–Johnson syndrome and toxic epidermal necrolysis: a clinical classification.J. Invest. Dermatol.102(6) , S28–S30 (1994).
  • Seo YS , ChangKC, ChangMH: Methazolamide-induced Stevens–Johnson Syndrome.J. Korean Ophthalmol. Soc.50(12) , 1881–1886 (2009).
  • Miller SA , DykesDD, PoleskyHF: A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic Acids Res.16(3) , 1215 (1988).
  • French LE : Toxic epidermal necrolysis and Stevens–Johnson syndrome: our current understanding.Allergol. Int.55(1) , 9–16 (2006).
  • Borchers AT , LeeJL, NaguwaSM, CheemaGS, GershwinME: Stevens–Johnson syndrome and toxic epidermal necrolysis.Autoimmun. Rev.7(8) , 598–605 (2008).
  • Pirmohamed M : Genetic factors in the predisposition to drug-induced hypersensitivity reactions.AAPS J.8(1) , E20–E26 (2006).
  • Chung WH , HungSI, ChenYT: Human leukocyte antigens and drug hypersensitivity.Curr. Opin. Allergy Clin. Immunol.7(4) , 317–323 (2007).
  • Sheffield LJ , PhillimoreHE: Clinical use of pharmacogenomic tests in 2009.Clin. Biochem. Rev.30(2) , 55–65 (2009).
  • Chung WH , HungSI, HongHS et al.: A marker for Stevens–Johnson syndrome.Nature428(6982) , 486 (2004).
  • Alfirevic A , JorgensenAL, WilliamsonPR, ChadwickDW, ParkBK, PirmohamedM: HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.Pharmacogenomics7(6) , 813–818 (2006).
  • Kaniwa N , SaitoY, AiharaM et al.: HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis.Pharmacogenomics9(11) , 1617–1622 (2008).
  • Lee JH , LeeSJ, KimYH: A case of Stevens–Johnson syndrome after acetazolamide use.J. Korean Ophthalmol. Soc.39(1) , 216–220 (1998).
  • Ha JH , SongJY, KimHO, KimJW: A case of Stevens–Johnson syndrome caused by acetazolamide.Korean J. Dermatol.41(2) , 248–250 (2003).
  • Kim JW , ShinSY: Toxic epidermal necrolysis and Stevens–Johnson syndrome caused by topical ophthalmic use of dorzolamide.Korean J. Dermatol.47(3) , 317–321 (2009).
  • Chun JS , YunSJ, LeeJB, KimSJ, WonYH, LeeSC: Toxic epidermal necrolysis induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide.Ann. Dermatol.20(4) , 260–262 (2008).
  • Roujeau JC , HuynhTN, BracqC, GuillaumeJC, RevuzJ, TouraineR. Genetic susceptibility to toxic epidermal necrolysis. Arch. Dermatol.123(9) , 1171–1173 (1987).
  • Lonjou C , BorotN, SekulaP et al.: A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.Pharmacogenet. Genomics.18(2) , 99–107 (2008).
  • Slatore CG , TillesSA: Sulfonamide hypersensitivity.Immunol. Allergy Clin. North Am.24(3) , 477–490 (2004).
  • Brackett CC , SinghH, BlockJH: Likelihood and mechanisms of crossallergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.Pharmacotherapy24(7) , 856–870 (2004).
  • Monnet D , BrézinAP: Birdshot chorioretinopathy.Curr. Opin. Ophthalmol.17(6) , 545–550 (2006).
  • Martin TM , KurzDE, RosenbaumJT: Genetics of uveitis.Ophthalmol. Clin. North Am.16(4) , 555–565 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.